These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 36994372)
1. Nationally representative surveys on cannabis use lack product details relevant to public health. Stith S; Pearson J; Brockelman F; Keeling K; Hall B; Friedman AS Drug Alcohol Depend Rep; 2023 Mar; 6():100134. PubMed ID: 36994372 [TBL] [Abstract][Full Text] [Related]
2. Understanding feeling "high" and its role in medical cannabis patient outcomes. Stith SS; Li X; Brockelman F; Keeling K; Hall B; Vigil JM Front Pharmacol; 2023; 14():1135453. PubMed ID: 37292156 [No Abstract] [Full Text] [Related]
3. The impacts of potency, warning messages, and price on preferences for Cannabis flower products. Shi Y; Cao Y; Shang C; Pacula RL Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201 [TBL] [Abstract][Full Text] [Related]
4. Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars. Vigil JM; Stith SS; Brockelman F; Keeling K; Hall B J Cannabis Res; 2023 Feb; 5(1):4. PubMed ID: 36755303 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of high-potency cannabis flower and cannabis concentrates on everyday life memory and decision making. Cuttler C; LaFrance EM; Stueber A Sci Rep; 2021 Jul; 11(1):13784. PubMed ID: 34215784 [TBL] [Abstract][Full Text] [Related]
6. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients. Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA Front Public Health; 2022; 10():893009. PubMed ID: 35784239 [TBL] [Abstract][Full Text] [Related]
7. The effectiveness of inhaled Cannabis flower for the treatment of agitation/irritability, anxiety, and common stress. Stith SS; Li X; Diviant JP; Brockelman FC; Keeling KS; Hall B; Vigil JM J Cannabis Res; 2020 Dec; 2(1):47. PubMed ID: 33526145 [TBL] [Abstract][Full Text] [Related]
8. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot. Pennypacker SD; Cunnane K; Cash MC; Romero-Sandoval EA Front Pharmacol; 2022; 13():921493. PubMed ID: 35734402 [No Abstract] [Full Text] [Related]
9. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada. Hammond D; Goodman S Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866 [No Abstract] [Full Text] [Related]
10. Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws. Hasin DS; Borodovsky J; Shmulewitz D; Walsh C; Livne O; Struble CA; Aharonovich E; Fink DS; Budney A Drug Alcohol Depend; 2021 Dec; 229(Pt B):109159. PubMed ID: 34844095 [TBL] [Abstract][Full Text] [Related]
11. Exploring cannabis concentrates on the legal market: User profiles, product strength, and health-related outcomes. Cinnamon Bidwell L; YorkWilliams SL; Mueller RL; Bryan AD; Hutchison KE Addict Behav Rep; 2018 Dec; 8():102-106. PubMed ID: 30167450 [TBL] [Abstract][Full Text] [Related]
12. Young adults' familiarity with different cannabis product terms: the need for standardized cannabis surveys. Berberian S; Broussard ML; Tully C; Methuku V; Pardini DA; Meier MH J Cannabis Res; 2022 Apr; 4(1):14. PubMed ID: 35365236 [TBL] [Abstract][Full Text] [Related]
13. Cannabis Consumption, Purchasing and Sources among Young Canadians: The Cannabis Purchase and Consumption Tool (CPCT). Sikorski C; Leos-Toro C; Hammond D Subst Use Misuse; 2021; 56(4):449-457. PubMed ID: 33593238 [TBL] [Abstract][Full Text] [Related]
14. Trends and Socio-Demographic Differences of Cannabis Vaping in the USA and Canada. Lim CCW; Chan GCK; Wadsworth E; Stjepanović D; Chiu V; Chung JYC; Sun T; Connor J; Leung J; Gartner C; Hall W; Hammond D Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361272 [TBL] [Abstract][Full Text] [Related]
15. Modes of marijuana use - smoking, vaping, eating, and dabbing: Results from the 2016 BRFSS in 12 States. Schauer GL; Njai R; Grant-Lenzy AM Drug Alcohol Depend; 2020 Apr; 209():107900. PubMed ID: 32061947 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Raw, Natural Medical Vigil JM; Stith SS; Diviant JP; Brockelman F; Keeling K; Hall B Medicines (Basel); 2018 Jul; 5(3):. PubMed ID: 29997343 [No Abstract] [Full Text] [Related]
17. Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints? Freeman TP; Morgan CJ; Hindocha C; Schafer G; Das RK; Curran HV Addiction; 2014 Oct; 109(10):1686-94. PubMed ID: 24894801 [TBL] [Abstract][Full Text] [Related]
18. Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes. Karoly HC; Mueller RL; Andrade CC; Hutchison KE Front Psychiatry; 2020; 11():613243. PubMed ID: 33408657 [TBL] [Abstract][Full Text] [Related]
19. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290 [TBL] [Abstract][Full Text] [Related]
20. Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults. Dunbar MS; Seelam R; Tucker JS; Firth CL; Pedersen ER; Klein DJ; Rodriguez A; D'Amico EJ Addict Behav; 2022 Mar; 126():107185. PubMed ID: 34839070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]